Keros Therapeutics (KROS) Accounts Payables (2019 - 2026)
Keros Therapeutics' Accounts Payables came in at $1.82 million for Q2 2026, down 65.5% from $5.27 million a year earlier.
Powered by 
Analysis
Keros Therapeutics (KROS) Accounts Payables (2019 - 2026) Analysis & Trends
At the end of FY2025, Keros Therapeutics' Accounts Payables was $1.97 million, down 57.3% from FY2024.
- Accounts Payables carries a five-year compound annual growth rate of -1.8% (FY2020 to FY2025).
- Going back by year, Accounts Payables was $4.6 million in FY2024 (-15.6%), $5.45 million in FY2023 (+63.2%), $3.34 million in FY2022 (-8.4%) and $3.65 million in FY2021 (+69.6%).
- The Q2 2026 figure represents the lowest quarterly Accounts Payables since Q2 2021.
- Year-over-year, Accounts Payables increased in two of the last seven quarters, with an average decline of 21.4%.
- The fastest year-over-year change in Accounts Payables over five years came in Q2 2022 (growth of 458.3%), and the weakest in Q2 2026 (a decline of 65.5%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 9.32 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 3.83 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 4.58 Bn |
| 10 | Keros Therapeutics | 224.56 Mn | -1.70 Bn | - | 1.82 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.82 Mn |
| Dec 31, 2025 | 1.97 Mn |
| Sep 30, 2025 | 2.30 Mn |
| Jun 30, 2025 | 5.27 Mn |
| Mar 31, 2025 | 6.64 Mn |
| Dec 31, 2024 | 4.60 Mn |
| Sep 30, 2024 | 4.98 Mn |
| Jun 30, 2024 | 6.54 Mn |
| Mar 31, 2024 | 4.99 Mn |
| Dec 31, 2023 | 5.45 Mn |
| Sep 30, 2023 | 3.87 Mn |
| Jun 30, 2023 | 4.15 Mn |
| Mar 31, 2023 | 4.68 Mn |
| Dec 31, 2022 | 3.34 Mn |
| Sep 30, 2022 | 2.66 Mn |
| Jun 30, 2022 | 7.66 Mn |
| Mar 31, 2022 | 3.06 Mn |
| Dec 31, 2021 | 3.65 Mn |
| Sep 30, 2021 | 2.81 Mn |
| Jun 30, 2021 | 1.37 Mn |
API Access
Keros Therapeutics Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=KROS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "KROS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=KROS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();